Fears for 4,000 GSK jobs
Drugs giant GlaxoSmithKline added to job woes in the sector today as it upped cost saving targets amid fears it plans to axe 4,000 roles.
The news comes a week after AstraZeneca revealed it was cutting another 8,000 jobs worldwide, on top of 12,600 job losses already made.